Commandez votre montre hebdomadaire Nuvalent, Inc.
Quantité totale PI	73
Rang # Quantité totale PI	18 771
Note d'activité PI	2,8/5.0    83
Rang # Activité PI	8 275
Symbole boursier	NUVL (nasdaq)
ISIN	US6707031075
Capitalisation	6,700M  (USD)
Classe Nice dominante	Produits pharmaceutiques, vétéri...

Brevets Marques 13 27 7 6 13 7 0
Dernier brevet	2025 - Methods of treating solid tumor ...
Premier brevet	2021 - Heteroaromatic macrocyclic ether...
Dernière marque	2025 - ROBORA
Première marque	2020 - NUVALENT

Industrie (Classification de Nice)

Derniers inventions, produits et services 2025 P/S Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders P/S Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders. P/S Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders. Invention Methods of treating solid tumor using heteroaromatic macrocyclic ether compounds. Provided herein... 2024 Invention Heteroaromatic macrocyclic ether compounds and isotopologues thereof. Provided herein are heteroa... Invention Heteroaromatic macrocyclic ether compounds. Provided herein are certain heteroaromatic macrocycli... Invention Heteroaromatic macrocyclic ether chemotherapeutic agents. Disclosed are heterocyclic heteroaroma... Invention Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether comp... Invention Amino-substituted heterocycles for treating cancers with egfr mutations. Disclosed are amino-sub... 2023 Invention Heteroaromatic macrocyclic ether chemotherapeutic agents. The application relates to heterocycli... Invention Heteroaromatic macrocyclic ether chemotherapeutic agents. The application relates to heterocyclic... Invention Heteroaromatic macrocyclic ether chemotherapeutic agents Invention Methods of treating solid tumor using (19r)-5-chloro-3-ethyl-16-fluoro-10,19-dimethyl-20-oxa-3,4,... 2022 Invention Methods of treating solid tumor using heteroaromatic macrocyclic ether compounds. Provided herei... Invention Heteroaromatic macrocyclic ether chemotherapeutic agents. Disclosed are heterocyclic heteroaromat... Invention Amino-substituted heteroaryls for treating cancers with egfr mutations. Disclosed are amino-subst... Invention Amino-substituted heterocycles for treating cancers with egfr mutations. Disclosed are amino-subs... 2021 P/S Pharmaceutical preparations for the treatment of cancer P/S Pharmaceutical preparations for the treatment of cancer. P/S Pharmaceutical preparations for the treatment of cancer.